Sarah BlackmoreViral Vector and Gene Therapy Technology Manager at Pall Biotech
Sarah Blackmore currently has the role of Viral Vector and Gene Therapy Technology Manager at Pall Biotech. She previously worked on the Pall Bioprocess Specialist team supporting process development projects with Pall technologies in the Northeast region from 2016-2021, with a focus on antibody, protein, vaccine, gene therapy and oligonucleotide processes. Before joining Pall, Sarah held roles in purification manufacturing and downstream process development at Amgen. She graduated from Cornell University with a bachelor’s degree in Biological Sciences and from Brown University with a master’s degree in Biotechnology.